MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING
***
Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants
“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“
A Partner of the Institute of Medical Business Advisors , Inc.
http://www.MedicalBusinessAdvisors.com
SPONSORED BY: Marcinko & Associates, Inc.
***
http://www.MarcinkoAssociates.com
Daily Update Provided By Staff Reporters Since 2007. How May We Serve You? |
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2024 |
REFER A COLLEAGUE: MarcinkoAdvisors@msn.com
SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/
ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z
***
CITE: https://www.r2library.com/Resource
Markets: Stocks dropped ever so slightly to end last week as investors tried to make sense of the big jobs report. Lots of jobs = good, but lots of jobs also = interest rates likely staying the same for awhile longer (more below). AMC had a rough day, tumbling 15% as the latest meme stock craze started to fizzle.
CITE: https://tinyurl.com/2h47urt5
Blue Kansas City Exiting MA Market by 2025 Due to ‘Regulatory Demands’
Blue Cross and Blue Shield of Kansas City (Blue KC) is leaving the Medicare Advantage (MA) market at the end of 2024, the insurer announced recently. The company blamed “heightened regulatory demands and rising market and financial pressures” for the decision but said it is still focused on employer-sponsored health plans, and Medicare supplement and Affordable Care Act plans in the state.
“We explored every alternative path for our MA members and are disappointed we must exit this line of business,” said Erin Stucky, Blue KC President and CEO, in a statement. “We value our MA members and are committed to providing uninterrupted, quality service to our current MA membership through the end of 2024.”
Source: Noah Tong, Fierce Healthcare [6/3/24]
CITE: https://tinyurl.com/tj8smmes
Cue Health, founded in 2010, started with great hopes as it promised a way to accurately test for Covid-19 without needing a lab. “We designed and developed a new molecular testing platform bringing lab complexity to an easy-to-use, portable device. Now you can get the best of lab molecular testing — speed, accuracy, and versatility – at home, the office, or on the go,” the company shared on its website. The company went public (with the ticker (HLTH) ) in 2021 at $16 and rose to $20.55 and carried that massive $2.3 billion valuation. Through 2023 and into this year, Cue unsuccessfully tried to shore up operations, get new products to market, and find new capital.
In May, however, the FDA advised customers not to use two of its products at all because they did not deliver accurate results. Finally, its board and executives threw in the towel. On May 28th, the company announced it was ceasing operations and filed for bankruptcy in Delaware’s U.S. Bankruptcy Court. The company’s assets will be sold off at an undetermined date, and the proceeds will be distributed to creditors.
***
Inflation data from the Fed meeting on Wednesday: Inflation data for May arrives in the morning, and it’s expected to show price growth held steady at 3.4% annually. In the afternoon, the FOMC will wrap up its meeting with a Jerome Powell press conference. The Fed is pretty much a lock to hold interest rates at their current level.
COMMENTS APPRECIATED
PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com
Thank You
***
***
***
***
EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf
***
Filed under: "Ask-an-Advisor", Breaking News, Experts Invited, Financial Planning, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors, Touring with Marcinko | Tagged: ACA, Affordable Care Act, AMC, CBOE, Cue Health, DJIA, FOMC, inflation, IRS, Jerome Powell, Marcinko, mediare c, medicare, Medicare Advantage, medicare supplement, NASDAQ, Part C, PPACA, S&P 500, stock markets, VIX | Leave a comment »